glp-1 receptor agonist brand names Agonists: A Comprehensive Overview GLP-1 Costs Explained: Managing Coverage
Description
The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 9.7% during the forecast period, till 2035
Transient nausea was more frequent with GLP-1RAs and should be addressed through patient education and an incremental dosing approach
M.HoustonD
Researchers not involved in the University of Pennsylvania study said it contributes to growing research involving GLP-1 drugs commonly prescribed for weight loss and to treat Type 2 diabetes
Weight loss interventions have potential benefits, but sustaining weight reduction in breast cancer patients is challenging
